Trial Profile
Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Aprepitant (Primary) ; Scopolamine (Primary) ; Desflurane; Dexamethasone; Dexmedetomidine; Fentanyl; Metoclopramide; Ondansetron; Prochlorperazine; Propofol; Sevoflurane; Sugammadex
- Indications Emesis; Nausea
- Focus Therapeutic Use
- 14 Jan 2019 Planned End Date changed from 20 Aug 2018 to 20 Aug 2019.
- 14 Jan 2019 Planned primary completion date changed from 20 Aug 2018 to 20 Aug 2019.
- 20 Feb 2018 New trial record